Statins for Primary Prevention: The Debate Is Intense, but the Data Are Weak

JAMA. 2016 Nov 15;316(19):1979-1981. doi: 10.1001/jama.2016.15085.

Authors

Rita F Redberg^{1

2}, Mitchell H Katz^{3

4}

Affiliations

¹ Department of Medicine, University of California, San Francisco.
² Editor.
³ County of Los Angeles, Department of Health Services, Los Angeles, California.
⁴ Deputy Editor.

PMID: 27838702
DOI: 10.1001/jama.2016.15085

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiovascular Diseases / drug therapy
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Primary Prevention*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors